Precigen (PGEN.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec23

Randal J. Kirk Sells Precigen Inc. Shares

01:49

Dec16

Jeffrey B. Kindler Sells Ordinary Shares of Precigen Inc.

21:17

Nov14

Precigen released FY2025 Q3 earnings on November 13 After-Market EST, actual revenue USD 2.922 M (forecast USD 500 K), actual EPS USD -1.0599 (forecast USD -0.095)

00:00

Precigen released FY2025 9 Months Earnings on November 13 After-Market EST, actual revenue USD 5.119 M, actual EPS USD -1.3333

00:00

Nov6

Precigen to Release FY2025 Q3 Earnings on November 13 After-Market EST, Forecast Revenue USD 666.67K, EPS USD -0.0933

00:09

Oct13

Precigen's PAPZIMEOS Receives FDA Approval for RRP Treatment

11:01

Schedules & Filings

Schedules

Filings

Nov13

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 2.922 M, Net Income -325.34 M, EPS -1.0591

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 856 K, Net Income -26.64 M, EPS -0.0898

May14

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.341 M, Net Income -54.15 M, EPS -0.1842

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change